As the Cost of Clinical Trials Climbs, Here Are 3 Ways to Save
By all accounts, the cost of clinical trials continues to rise. We hear reasons that include increasing protocol complexity, patient recruitment struggles, or regulatory challenges.…
Molly Bryant
Clinical Operations Conferences Roundup: 37 Events that Are Happening in 2021 [UPDATED]
Updated 22 July 2021. 2020 completely rocked the schedule of clinical operations conferences by the…
Molly Bryant
Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya
Peju Oshisanya joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
Successful Clinical Trial Management Now Means Accepting Complexity. Here’s How to Deal with It.
If it shocks you to hear that clinical trials are getting more complex, you haven’t…
Molly Bryant
As the Cost of Clinical Trials Climbs, Here Are 3 Ways to Save
By all accounts, the cost of clinical trials continues to rise. We hear reasons that…
Molly Bryant
A Decentralized Clinical Trial Requires Training at Scale. Here’s What That Means.
The decentralized clinical trial is one of the most talked-about emerging trends in the life…
Molly Bryant
5 Challenges in Working with CROs – and How to Overcome Them
You have a clinical trial starting soon. Are you working with a contract research organization,…
Molly Bryant
How Can We Manage the Increasing Complexity of Clinical Trial Protocols?: Interview with Ken Getz of Tufts Center for the Study of Drug Development
Ken Getz joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
An Honest Look at How Demanding Oncology Trials Have Become: Interview with Rebecca Setta of Oncosec
Rebecca Setta joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
Got a Clinical Trial Startup Post-COVID? Plan to Tackle 3 Big Challenges
There are still a lot of challenges facing pharmaceuticals, med tech, and biotech companies that…
Molly Bryant
Decentralized, virtual, or hybrid clinical trial – what’s the difference?
Increased diversity. Faster enrollment. Reduction in costs. These are just a few of the myriad…
Molly Bryant
Industry insights you won’t delete. Delivered to your inbox monthly.
What Do You Do When You Don’t Have Enough Clinical Trial Locations: Interview with Krystyna Kowalczyk of Oncobay
Krystyna Kowalczyk joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Molly Bryant
When Seeking Diversity during Site Selection, Look Beyond Historical Data to Discover Untapped Patient Populations
We recently spoke with Liz Beatty, Chief Strategy Officer at Inato about how the company…
Molly Bryant
Attending Outsourcing in Clinical Trials West 2021? Join ArcheMedX There!
Along with most major clinical operations conferences, the Outsourcing in Clinical Trials event series is…
Molly Bryant
Choosing a Solution to Train Clinical Trial Site Staff Virtually? Start With this Checklist.
Choosing the right way to train clinical trial staff is complex and exhausting under normal…
Molly Bryant
Helping Sites and Teams Make the Shift to Decentralized Trials: Interview with Paul Evans of Velocity Clinical Research
Paul Evans of Velocity Clinical Research talks with Kelly Ritch, EVP of Product and Clinical…
Molly Bryant
7 Tips to Transform Your Clinical Trial Site Training Content for Virtual Use
When was the last time you conducted a face-to-face clinical trial site training for anyone?…
Molly Bryant
Experience ArcheMedX For Yourself
See how the ArcheMedX Platform can transform your organization’s learning and insights